We applied IMPALA to a gene expression (microarray) dataset (termed Loi) including samples from Tamoxifen-treated ER positive breast cancer patients16 and identified aberrant signal pathway transduction associated with Tamoxifen resistance. This evidence concerns the gene ESR1 and breast carcinoma.